Concepedia

Author

Mary E. Russell

Brigham and Women's HospitalORCID

Also Known As

David Greer, Eric Rosenthal, Jeffrey J. Popma, M E Russell, M Russell, M. E. Russell, M. Russell, M.E. Russell, MARY E. RUSSELL, Mario Rosanova

209

Publications

19.5K

Citations

61

H-Index

154

Concepts

All Affiliations

Brigham and Women's HospitalHarvard UniversityBoston Scientific (United States)Cardiovascular Research FoundationCleveland Clinic
ME

About

Mary E. Russell is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

36

51

7.7K

2

Public Health

7

7

2.8K

3

Health Sciences

6

6

1.5K

4

Natural Sciences

5

5

956

5

Engineering

2

2

101

Mary E. Russell

×

106

Publications

19.1K

Citations

61

H-Index

YearCitations

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Gregg W. Stone, Stephen G. Ellis, David A. Cox,

New England Journal of Medicine

2004

2.7K

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

Georgios Sianos, Marie‐Angèle Morel, Arie Pieter Kappetein,

PubMed

2005

2.3K

Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

Antonio Colombo, J Drzewiecki, Adrian Banning,

Circulation

2003

1K

TAXUS I

Eberhard Grube, Sigmund Silber, Karl Eugen Hauptmann,

Circulation

2003

865

Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements

J Wang, J. Thornton, Mary E. Russell,

American Journal of Clinical Nutrition

1994

830

Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease

Gregg W. Stone, Stephen G. Ellis, Louis Cannon,

JAMA

2005

764

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent

Gregg W. Stone, Stephen G. Ellis, David A. Cox,

Circulation

2004

760

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine:  A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties

Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi,

Journal of Medicinal Chemistry

2003

609

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

M H Sayegh, Enver Akalin, W W Hancock,

The Journal of Experimental Medicine

1995

518

The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase

Andrew T.L. Ong, Patrick W. Serruys, Frederick W. Mohr,

American Heart Journal

2006

336

Page 1